[
  {
    "ts": "2025-06-09T13:29:00+00:00",
    "headline": "3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats",
    "summary": "Sandoz, Teva and Viatris are navigating generic drug pricing pressure with scale, complex generics and cost cuts.",
    "url": "https://finance.yahoo.com/news/3-generic-drug-stocks-watch-132900658.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "247c5159-a5da-3497-bfea-afaf500d95e5",
      "content": {
        "id": "247c5159-a5da-3497-bfea-afaf500d95e5",
        "contentType": "STORY",
        "title": "3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats",
        "description": "",
        "summary": "Sandoz, Teva and Viatris are navigating generic drug pricing pressure with scale, complex generics and cost cuts.",
        "pubDate": "2025-06-09T13:29:00Z",
        "displayTime": "2025-06-09T13:29:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/eb91dd38215d2ebcc27e91d2c63b0c98",
          "originalWidth": 900,
          "originalHeight": 587,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oIA2RPTTkSv_l1IwwmcLYA--~B/aD01ODc7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/eb91dd38215d2ebcc27e91d2c63b0c98.cf.webp",
              "width": 900,
              "height": 587,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_E.140T78.y_sF4wxOmO7A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/eb91dd38215d2ebcc27e91d2c63b0c98.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-generic-drug-stocks-watch-132900658.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-generic-drug-stocks-watch-132900658.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TEVA"
            },
            {
              "symbol": "VTRS"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-06-09T11:22:55+00:00",
    "headline": "VTRS Q1 Earnings Call: Pipeline Advances, Tariff Risks, and Strategic Cost Review",
    "summary": "Medication company Viatris (NASDAQ:VTRS) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 11.2% year on year to $3.25 billion. Its non-GAAP EPS of $0.50 per share was 2.3% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/vtrs-q1-earnings-call-pipeline-112255871.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "d672013d-0146-348d-862a-b8099b21a697",
      "content": {
        "id": "d672013d-0146-348d-862a-b8099b21a697",
        "contentType": "STORY",
        "title": "VTRS Q1 Earnings Call: Pipeline Advances, Tariff Risks, and Strategic Cost Review",
        "description": "",
        "summary": "Medication company Viatris (NASDAQ:VTRS) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 11.2% year on year to $3.25 billion. Its non-GAAP EPS of $0.50 per share was 2.3% above analysts’ consensus estimates.",
        "pubDate": "2025-06-09T11:22:55Z",
        "displayTime": "2025-06-09T11:22:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/ad9a5e2f85d880e3e7b521395022f4d3",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "VTRS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZ5PSZg5aKFn_8IHve8fGQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/ad9a5e2f85d880e3e7b521395022f4d3.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4bPZw8EZ18ugKQPfipbnLw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/ad9a5e2f85d880e3e7b521395022f4d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/vtrs-q1-earnings-call-pipeline-112255871.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vtrs-q1-earnings-call-pipeline-112255871.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]